BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tarao K, Nozaki A, Komatsu H, Komatsu T, Taguri M, Tanaka K, Chuma M, Numata K, Maeda S. Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases. World J Hepatol 2020; 12(11): 1046-1054 [PMID: 33312428 DOI: 10.4254/wjh.v12.i11.1046]
URL: https://www.wjgnet.com/1007-9327/full/v12/i11/1046.htm
Number Citing Articles
1
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvementExpert Review of Anticancer Therapy 2022; 22(4): 371 doi: 10.1080/14737140.2022.2052276
2
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical SignificanceCancers 2021; 13(10): 2454 doi: 10.3390/cancers13102454
3
Yang Yang, Guangbing Li, Ziwen Lu, Yong Liu, Junjie Kong, Jun Liu. Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular CarcinomaFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.726213
4
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Emi Noguchi, Kazuki Sudo, Kan Yonemori. Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective studyBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09514-3
5
Tanita Suttichaimongkol, Manoon Mitpracha, Kawin Tangvoraphonkchai, Phuangphaka Sadeea, Kittisak Sawanyawisuth, Wattana Sukeepaisarnjaroen. PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patientsJournal of Circulating Biomarkers 2023; 12: 12 doi: 10.33393/jcb.2023.2453
6
Kazuo Tarao, Akito Nozaki, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka, Testuo Yoshida, Hideki Koyasu, Makoto Chuma, Kazushi Numata, Shin Maeda. Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinomaWorld Journal of Hepatology 2021; 13(6): 699-708 doi: 10.4254/wjh.v13.i6.699
7
Nia Adeniji, Renumathy Dhanasekaran. Current and Emerging Tools for Hepatocellular Carcinoma SurveillanceHepatology Communications 2021; 5(12): 1972 doi: 10.1002/hep4.1823
8
Amina Tawfik, Samia Shouman, Reda Tabashy, Mervat Omran, Mohamed Gad El-Mola. Evaluation of doxorubicin administrations in hepatocellular carcinoma in terms of genetic polymorphism, case study: EgyptArab Gulf Journal of Scientific Research 2023;  doi: 10.1108/AGJSR-04-2023-0158